Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: GMED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on GMED, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 905,984 GMED shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 905,984 shares
    Change vs previous 13F +8,377 shares

    1.31% of the 13F portfolio, value $71,581,796.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 897,607 shares
    Change vs previous 13F -9,226 shares

    1.49% of the 13F portfolio, value $77,337,819.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 906,833 shares
    Change vs previous 13F +15,790 shares

    1.66% of the 13F portfolio, value $79,181,526.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 891,043 shares
    Change vs previous 13F +889,229 shares

    1.14% of the 13F portfolio, value $51,033,882.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,814 shares
    Change vs previous 13F +67 shares

    <0.01% of the 13F portfolio, value $107,070.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,747 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $127,891.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).